MedImmune Study Drug Invention definition

MedImmune Study Drug Invention means all inventions relating to or derived from the Study Drug including, without limitation, new indications or uses thereof, that are conceived, generated or otherwise made by the Institution, or any of its representatives, or the Investigator whether solely or jointly with others, under or in connection with the Study. For the avoidance of doubt, MedImmune Study Drug Inventions also include any inventions relating (a) to the Study Drug metabolic activity, pharmacological activity, side effects, drug metabolism, mechanism of action, safety, or drug interactions, or (b) to biomarkers, assays, diagnostic methods or diagnostic products, which may be used to predict patient response or resistance to the MedImmune Study Drug or be used in any way to select patients for treatment with the MedImmune Study Drug.
MedImmune Study Drug Invention means all inventions relating to or derived from the Study Drug including, without limitation, new indications or uses thereof, that are conceived, generated or otherwise made by the Institution, or any of its representatives, or the Investigator whether solely or jointly with others, under or in connection with the Study. For the avoidance of doubt, MedImmune Study Drug Inventions also include any inventions relating (a) to the Study Drug metabolic activity, pharmacological activity, side effects, drug metabolism, mechanism of action, safety, or drug interactions, or (b) to biomarkers, assays, diagnostic methods or diagnostic products, which may be used to predict patient response or resistance to the MedImmune Study Drug or be used in any way to select patients for treatment with the MedImmune Study Drug. softwaru, procesům, zásadám, metodám, technikám a dalším informacím, včetně patentů, ochranných známek, servisních značek, obchodních názvů, průmyslových vzorů, práv na vzory, autorských práv a dalších podobných práv či vlastnictví kdekoliv xx xxxxx, registrovaných i neregistrovaných, společně s právem požádat o registraci těchto práv.
MedImmune Study Drug Invention means all inventions relating to or derived from the Study Drug including, without limitation, new indications or uses thereof, that are conceived, generated or otherwise made by the Institution, or any of its representatives, or the Investigator whether solely or jointly with others, under or in connection with the Study. For the avoidance of doubt, MedImmune Study Drug Inventions also include any inventions relating (a) to the

Related to MedImmune Study Drug Invention

  • Manufacturing Technology means any and all patents, patent applications, know-how, and all intellectual property rights associated therewith that are owned or controlled by Licensor, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno-associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Product Technology means the Product Know-How and Product Patents.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Compound means [***].

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.

  • Manufacturing Know-How means all information, techniques, inventions, discoveries, improvements, practices, methods, knowledge, skill, experience and other technology, whether or not patentable or copyrightable, and any copyrights based thereon, relating to or necessary or useful for the production, purification, packaging, storage and transportation of Collaboration Products, including without limitation specifications, acceptance criteria, manufacturing batch records, standard operating procedures, engineering plans, installation, operation and process qualification protocols for equipment, validation records, master files submitted to the FDA, process validation reports, environmental monitoring processes, test data including pharmacological, toxicological and clinical test data, cost data and employee training materials.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Joint Invention has the meaning set forth in Section 9.1.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Joint Inventions has the meaning set forth in Section 9.1.

  • Developed Technology means any Technology including, without limitation, any enhancements, substitutions or improvements to the Core Technology that is (a) discovered, developed or otherwise acquired by DURA pursuant to the terms of the Development Agreement or (b) otherwise acquired by or on behalf of Xxxxxx Corp. II during the term of the Development Agreement.

  • Merck has the meaning set forth in the preamble.

  • Program Technology means Program Know-How and Program Patents.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Subject Invention means any invention of the contractor conceived or first actually reduced to practice in the performance of work under this contract, provided that in the case of a variety of plant, the date of determination (as defined in section 41(d) of the Plant Variety Protection Act, 7 U.S.C. 2401(d)) must also occur during the period of contract performance.

  • Licensee Technology means the Licensee Know-How and Licensee Patents.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.